KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other financing activities (2021 - 2024)

Ginkgo Bioworks Holdings filings provide 4 years of Other financing activities readings, the most recent being $4000.0 for Q4 2024.

  • On a quarterly basis, Other financing activities fell 99.66% to $4000.0 in Q4 2024 year-over-year; TTM through Dec 2025 was $1.2 million, a 0.08% change, with the full-year FY2023 number at $580000.0, changed N/A from a year prior.
  • Other financing activities hit $4000.0 in Q4 2024 for Ginkgo Bioworks Holdings, up from -$4000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $59.8 million in Q3 2021 to a low of -$25.7 million in Q2 2021.
  • Median Other financing activities over the past 4 years was $1500.0 (2023), compared with a mean of $6.2 million.
  • Biggest five-year swings in Other financing activities: soared 1582.09% in 2022 and later plummeted 300.0% in 2024.
  • Ginkgo Bioworks Holdings' Other financing activities stood at -$67000.0 in 2021, then soared by 1582.09% to $993000.0 in 2022, then rose by 19.23% to $1.2 million in 2023, then plummeted by 99.66% to $4000.0 in 2024.
  • The last three reported values for Other financing activities were $4000.0 (Q4 2024), -$4000.0 (Q3 2024), and $1.2 million (Q4 2023) per Business Quant data.